Clinical Comparison of 27-gauge and 23-gauge Instruments on the Outcomes of Pars Plana Vitrectomy Surgery for the Treatment of Vitreoretinal Diseases
Overview
Authors
Affiliations
Purpose Of Review: To compare outcomes of 27-gauge and 23-gauge pars plana vitrectomy (PPV) for treatment of vitreoretinal diseases.
Recent Findings: Sixty-eight patients undergoing microincisional PPV for treatment of vitreoretinal diseases were randomized 1 : 1 to 27-gauge or 23-gauge surgery with a 7500 cuts-per-minute vitrectomy probe. The most common reasons for vitrectomy were epiretinal membrane (49%) and vitreous hemorrhage (24%). Mean ± standard deviation (SD) changes from immediate preoperative to immediate postoperative intraocular pressure were -0.40 ± 6.60 mmHg in the 27-gauge and -3.05 ± 7.64 mmHg in the 23-gauge group (adjusted mean difference 2.42 mmHg, 95% lower confidence limit 0.64, P = 0.013), but these changes were not associated with primary reason for vitrectomy (P = 0.065). Mean ± SD conjunctival edema grades in the 27-gauge and 23-gauge groups 1 week after surgery were 0.02 ± 0.124 and 0.10 ± 0.246, respectively (least squares mean difference -0.09, 95% upper confidence limit -0.03, P = 0.004), and were 0.01 ± 0.122 and 0.12 ± 0.338, respectively, at the probe incision site. Conjunctival edema grades were similar in both groups at 1 and 3 months. Mean ± SD pain ratings on postoperative day 1 - an indicator of patient comfort - were similar in the two groups.
Summary: Smaller diameter vitrectomy instruments are associated with smaller reductions in immediate postoperative intraocular pressure.
Hammer M, Herth J, Herbster L, Bohmann M, Muuss M, Khoramnia R Gels. 2024; 10(8).
PMID: 39195030 PMC: 11353491. DOI: 10.3390/gels10080501.
Caretti L, Pillon G, Verzola G, Monterosso C, Formisano M J Curr Ophthalmol. 2024; 35(3):259-266.
PMID: 38681686 PMC: 11047808. DOI: 10.4103/joco.joco_318_22.
Recent advances in the treatment and delivery system of diabetic retinopathy.
Wang Z, Zhang N, Lin P, Xing Y, Yang N Front Endocrinol (Lausanne). 2024; 15:1347864.
PMID: 38425757 PMC: 10902204. DOI: 10.3389/fendo.2024.1347864.
Ng E, Masalkhi M, Steel D, Pavicic-Astalos J, Nolan C, Mernagh S BMC Ophthalmol. 2023; 23(1):518.
PMID: 38129776 PMC: 10734045. DOI: 10.1186/s12886-023-03265-w.
Yamaguchi S, Yoshikawa Y, Chino M, Shinoda K Case Rep Ophthalmol. 2023; 14(1):607-612.
PMID: 37942233 PMC: 10629856. DOI: 10.1159/000534501.